parasitic%20infections
PARASITIC INFECTIONS
Gastrointestinal parasitic infection symptoms include abdominal pain, diarrhea, dysentery, flatulence, malabsorption and symptoms of biliary obstruction.
It can be caused by protozoan parasites and helminths.
Host susceptibility factors in gastrointestinal parasitic infections are nutritional status, intercurrent disease, pregnancy, immunosuppressive drugs and presence of a malignancy.
Knowledge of the geographic distribution of parasites is helpful in the diagnosis of patients.

Follow Up

  • Repeat laboratory exams to document eradication of parasite, if necessary

Prevention

  • Health education regarding personal hygiene, routes of transmission & prevention of transmission
  • Handwashing to interrupt the fecal-oral or urinary-oral route of transmission of many parasites
  • Good food hygiene eg washing all vegetables & fruits before consumption to interrupt fecal-oral transmission
    • Kitchen utensils must be washed frequently
    • Meat & fish must be properly cooked
  • Use of footwear to inhibit the soil-to-skin route of infection
  • Targeted chemotherapy may prevent infections, like treating family contacts of a patient w/ certain parasitic infections eg enterobiasis
  • Proper disposal of sewage & wastewater to avoid contamination of food crops or water supplies by fecal material
  • Compost of human waste to kill infective forms of parasites
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 May 2014

New drug applications approved by US FDA as of 15-30 May which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

12 Apr 2017
Patients with fibromyalgia syndrome (FMS) are at an increased risk of peptic ulcer disease (PUD), a new study shows.
08 May 2017
Transabdominal bowel wall ultrasonography shows utility in monitoring disease activity in patients with active Crohn’s disease (CD), according to a study. The imaging technique is ideal for evaluating early transmural changes in disease activity, in response to medical treatment.
01 Jun 2015
A mixture of the flavonoids diosmin, troxerutin, and hesperidin is safe and effective for the symptomatic management of patients with acute haemorrhoidal disease, a prospective, randomised, triple-blind, controlled trial revealed.